The current price of BBIO is $74.27 — it has decreased by 4.65% since the previous close. Data as of Nov 5, 2026.
BBIO is up 1.95% over the past week, up 12.29% over the past month and up 18.53% over the past year. The price is above its 200-day moving average of $72.73.
Analysts' average 12-month price target for BBIO is $112.83, which implies 51.92% upside from the current price. Individual estimates range from $87.00 to $156.00.
Of the 22 analysts covering BridgeBio Pharma, Inc., 5 rate it a strong buy, 14 rate it a buy and 3 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
BridgeBio Pharma, Inc. has a market capitalization of $14.47B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, BridgeBio Pharma, Inc. posted a loss of $0.42 per share against an estimate of -$0.5423, beating expectations by 22.54%. Upcoming reports are listed in the earnings calendar.
BridgeBio Pharma, Inc. reported revenue of $353.17M in its most recent quarter, which has increased by 192.60% compared with the same quarter a year earlier. Analysts had expected $293.47M.
BridgeBio Pharma, Inc. has not paid any dividends over the past year.
Companies most comparable to BridgeBio Pharma, Inc. include Alnylam Pharmaceuticals, Inc., Ascendis Pharma A/S, BioMarin Pharmaceutical Inc., Ionis Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
In the latest trading session BBIO moved between $74.11 and $78.58, a range of 6.02% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of BridgeBio Pharma, Inc. shows a buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for BridgeBio Pharma, Inc. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks BBIO has traded between $60.55 and $93.42. The current price is 20.50% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.